Jennifer Chien Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity

Jennifer Chien is EVP, Head of North America of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 5,858 shares of RYTM, which is worth approximately $304,850. The most recent transaction as insider was on Nov 09, 2023, when has been sold 3,438 shares (Common Stock) at a price of $6.8 per share, resulting in proceeds of $23,378. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.86K

502.67% 3M change

14.51% 12M change

Total Value Held $304,850

Jennifer Chien Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 09 2023	BUY Exercise of conversion of derivative security	$23,378 $6.8 p/Share	3,438 Added 40.34%	5,085 Common Stock
Nov 08 2023	SELL Open market or private sale	$165,476 $28.97 p/Share	5,712 Reduced 77.62%	1,647 Common Stock
Nov 08 2023	BUY Exercise of conversion of derivative security	$38,841 $6.8 p/Share	5,712 Added 43.7%	7,359 Common Stock
Nov 03 2023	SELL Open market or private sale	$2,240 $28.0 p/Share	80 Reduced 4.63%	1,647 Common Stock
Nov 03 2023	BUY Exercise of conversion of derivative security	$544 $6.8 p/Share	80 Added 4.43%	1,727 Common Stock
Sep 05 2023	SELL Open market or private sale	$172,956 $28.05 p/Share	6,166 Reduced 78.92%	1,647 Common Stock
Sep 05 2023	BUY Exercise of conversion of derivative security	$30,729 $6.8 p/Share	4,519 Added 36.64%	7,813 Common Stock
Aug 09 2023	SELL Open market or private sale	$42,365 $24.66 p/Share	1,718 Reduced 34.28%	3,294 Common Stock
Aug 09 2023	BUY Exercise of conversion of derivative security	$11,682 $6.8 p/Share	1,718 Added 25.53%	5,012 Common Stock
Aug 07 2023	SELL Open market or private sale	$271,372 $24.18 p/Share	11,223 Reduced 77.31%	3,294 Common Stock
Aug 07 2023	BUY Exercise of conversion of derivative security	$58,418 $6.8 p/Share	8,591 Added 37.18%	14,517 Common Stock
Feb 14 2023	SELL Open market or private sale	$17,062 $26.87 p/Share	635 Reduced 11.39%	4,940 Common Stock
Feb 11 2023	BUY Exercise of conversion of derivative security	-	2,031 Added 26.7%	5,575 Common Stock
Feb 09 2023	SELL Open market or private sale	$32,970 $27.66 p/Share	1,192 Reduced 25.11%	3,556 Common Stock
Feb 09 2023	BUY Exercise of conversion of derivative security	-	3,438 Added 42.0%	4,748 Common Stock
Feb 15 2022	SELL Open market or private sale	$4,404 $6.1 p/Share	722 Reduced 35.53%	1,310 Common Stock
Feb 11 2022	BUY Exercise of conversion of derivative security	-	2,032 Added 50.0%	2,032 Common Stock

Jennifer Chien

EVP, Head of North America

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RYTM shares.

Notify only if

Value

Insider Trading

Get notified when an Rhythm Pharmaceuticals, Inc. insider buys or sells RYTM shares.

Notify only if

Operation

Value

Type

News

Receive news related to RHYTHM PHARMACEUTICALS, INC.

Track Activities on RYTM

Account